Levy is an American neurosurgeon who played a role in the development and testing of thrombectomy,[1] which improved quality of life and survival of stroke patients.

He has focused his career and research on developing evidence based medicine and literature showing the benefits of thrombectomy for the treatment of stroke.

[11] In 2020 Levy received his appointment as Distinguished Professor at the State University of New York at Buffalo due to his contributions to research, innovation, leadership and academia.

Following in the footsteps of Dr. Peter Jannetta, the "father of microvascular decompression," and Dr. Dade Lunsford, who introduced Gamma-knife radiosurgery to the University of Pittsburgh, Levy pursued minimally invasive endovascular neurosurgery by spending 2 years of his residency in Buffalo, as a fellow under Dr. L. Nelson Hopkins, the "father of neurointerventional surgery".

[15] In later years, Levy also completed his Master of Business Administration at Northeastern University and graduated magna cum laude in 2013.

[11] Levy started his academic and professional career as an associate professor of neurosurgery and radiology at the State University of New York (SUNY) at Buffalo in 2004.

The following year in 2005, he became the Director for Stroke Research, and co-director of Cerebrovascular Surgery at the Department of Neurosurgery, SUNY at Buffalo.

[33] Levy is the Principal investigator for the COMMAND trial and in 2023 he became the first surgeon to implant the stentrode, a novel stent in that is used for brain computer interface to help patients with limited mobility to operate technology such as mobile devices and computers using their thoughts helping these patients gain back independence.